Lamptey, Jorginho, Loftus-Cheek and Pulisic – Chelsea team news and expected line-up vs Brighton

Chelsea will look to start 2020 just as they ended 2019.

And that’s with all three points as they travel to the Amex Stadium to face Brighton and Hove Albion on New Year’s Day, three days removed from beating Arsenal at the Emirates Stadium.

Spurred on by the chance to complete a unique double over the two north London clubs, the Blues came from behind to win 2-1 thanks to a pair of late second half goals from Jorginho and Tammy Abraham.

Video Loading

Video Unavailable

Click to play
Tap to play

The video will start in 8Cancel

Play now

Attentions now turn to the clash against the Seagulls.

In the reverse meeting between the two clubs at Stamford Bridge earlier in the season, Chelsea emerged 2-0 winners with Jorginho on target from the penalty spot and Willian also on the scoresheet.

Frank Lampard faces an anxious wait to see how his players have recovered from such a hectic festive period as he plots to complete a league double over Graham Potter.

But what’s the latest team news surrounding the Blues?

Football.london takes a look.

The good news is that there are no fresh injuries to report.

Read More
Related Articles
Read More
Related Articles

Reece James, Ruben Loftus-Cheek, Olivier Giroud and Marco van Ginkel all missed the win over the Gunners and Premier Injuries don’t have a return date set for any of the quartet.

However, Marcos Alonso and Christian Pulisic are rated at 50% to return to the matchday squad.

Emerson Palmieri, Fikayo Tomori and Mateo Kovacic were all substituted against Arsenal, but those were for tactical reasons rather than injury related so the trio should be in contention to face Brighton.

Stay up to date with all the latest with all the latest Chelsea news from Oliver Harbord and the team at football.london across our social media channels.

Twitter: You can follow our dedicated Chelsea Twitter account, our Chelsea correspondent Oliver Harbord and senior reporter Alan Smith.

Facebook: You can follow our…